October 25, 2025 - 20:11

Westwater Resources, a company dedicated to advancing energy technology and critical minerals, has achieved a significant milestone by receiving a US patent for its novel graphite purification methods. This groundbreaking technology is set to be implemented at the Kellyton Graphite Processing Plant, which is currently under construction in Alabama.
The patent application was initially filed in August 2020, marking the beginning of a journey towards enhancing the production of battery-grade natural graphite. Unlike traditional purification processes, the patented method promises to improve efficiency and reduce environmental impact, positioning Westwater at the forefront of sustainable mineral processing.
As the demand for high-quality graphite continues to surge, particularly in the electric vehicle and renewable energy sectors, this innovation could play a crucial role in meeting industry needs. The successful patent acquisition not only underscores Westwater's commitment to innovation but also highlights its strategic importance in the evolving landscape of critical minerals.
August 4, 2026 - 19:37
When Tech Outpaces the Pentagon's Buying PowerThe gap between how fast private industry develops new technology and how quickly the government can buy it is getting wider, and that mismatch is creating real problems for national defense....
August 4, 2026 - 03:37
Idaho, Utah among finalists for nuclear waste, nuclear technology sitesFederal officials have narrowed the list of potential locations for a major nuclear waste management and technology complex, and both Idaho and Utah are still in the running. The chosen campuses...
August 3, 2026 - 01:31
Credo Technology Stock (CRDO) Opinions on AI Infrastructure ExpansionRecent discussions among investors and industry watchers have shifted focus to Credo Technology and its role in the rapidly expanding AI data center market. The conversation centers on the...
August 2, 2026 - 00:47
FDA weighs a new kind of flu shot based on technology RFK Jr. has questionedThe Food and Drug Administration is nearing a decision on a new type of influenza vaccine developed by Moderna, one that uses the same messenger RNA platform behind the company`s COVID-19 shots. If...